TARO Stock Ownership Activity
TARO PHARMACEUTICAL INDUS 13F holders
No value investing guru has made any change to the TARO PHARMACEUTICAL INDUS (TARO) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying TARO now?
According to the latest SEC filing(s) TARO PHARMACEUTICAL INDUS (TARO) has not been purchased by any super investor.
To see more about who is investing in TARO PHARMACEUTICAL INDUS (TARO), please go to the TARO ownership page.
2013 Q3
(1 result)
Current price: $42.98
23.11%
Reported price*: $55.90
2013 Q2
(1 result)
Current price: $42.98
23.11%
Reported price*: $55.90
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.